GSK, others eyeing acquisition of Brazil's 4th largest drugmaker

02/12/2013 | Reuters

Several drugmakers, including GlaxoSmithKline and likely Novartis, Pfizer and Abbott Laboratories, are looking at acquiring Brazil's Ache Laboratorios Farmaceuticos for up to $4 billion to increase their share in Latin America's pharmaceutical industry. Ache is the fourth-largest drugmaker in Brazil, but it ranks first in prescription drugs and is growing its over-the-counter business.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX